Pages that link to "Q39291910"
Jump to navigation
Jump to search
The following pages link to Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials (Q39291910):
Displaying 50 items.
- Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic review (Q26781036) (← links)
- Is There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma? (Q26796522) (← links)
- Cholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopy (Q26823868) (← links)
- Optimum chemotherapy for the management of advanced biliary tract cancer (Q27010873) (← links)
- Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review (Q28069495) (← links)
- Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers (Q28073195) (← links)
- Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors. (Q33442862) (← links)
- Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials (Q33556487) (← links)
- Treatment of advanced Gall bladder cancer in the real world-can continuation chemotherapy improve outcomes? (Q33593225) (← links)
- Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups (Q33757122) (← links)
- MiR-199a-3p enhances cisplatin sensitivity of cholangiocarcinoma cells by inhibiting mTOR signaling pathway and expression of MDR1 (Q33779591) (← links)
- Chemotherapy and targeted therapy for gall bladder cancer (Q33977171) (← links)
- Systemic Therapy of Cholangiocarcinoma (Q34551877) (← links)
- Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer (Q34779286) (← links)
- Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models (Q34898364) (← links)
- Endoscopic inside stent placement is suitable as a bridging treatment for preoperative biliary tract cancer (Q35068427) (← links)
- Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review (Q35871195) (← links)
- Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma. (Q36190116) (← links)
- Biliary tract cancers: SEOM clinical guidelines (Q36400234) (← links)
- Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection (Q36529570) (← links)
- Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice (Q36544718) (← links)
- Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models. (Q36667840) (← links)
- Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient. (Q36834539) (← links)
- Phenylethyl isothiocyanate reverses cisplatin resistance in biliary tract cancer cells via glutathionylation-dependent degradation of Mcl-1 (Q36962940) (← links)
- Dual-modality imaging demonstrates the enhanced antitumoral effect of herpes simplex virus-thymidine kinase/ganciclovir plus gemcitabine combination therapy on cholangiocarcinoma (Q37001522) (← links)
- Extensive Metastatic Cholangiocarcinoma Associated With IgG4-Related Sclerosing Cholangitis Misdiagnosed as Isolated IgG4-Related Sclerosing Cholangitis: A Case Report and Literature Review (Q37016845) (← links)
- Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design (Q37017110) (← links)
- Quality of life, long-term survivors and long-term outcome from the ABC-02 study (Q37175064) (← links)
- Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma (Q37314018) (← links)
- Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients (Q37534719) (← links)
- Intrahepatic cholangiocarcinoma: current perspectives. (Q37669928) (← links)
- Intra-arterial embolotherapy for intrahepatic cholangiocarcinoma: update and future prospects (Q37675072) (← links)
- Combination of Photon and Carbon Ion Irradiation with Targeted Therapy Substances Temsirolimus and Gemcitabine in Hepatocellular Carcinoma Cell Lines (Q37694481) (← links)
- MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer (Q37696266) (← links)
- Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study (Q37725603) (← links)
- Outcomes in biliary malignancy (Q38253816) (← links)
- The diagnosis and treatment of cholangiocarcinoma (Q38269945) (← links)
- Exceptional Response to Nanoparticle Albumin-Bound Paclitaxel and Gemcitabine in a Patient with a Refractory Adenocarcinoma of the Ampulla of Vater (Q38344071) (← links)
- Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients (Q38673037) (← links)
- Gene and microRNA modulation upon trabectedin treatment in a human intrahepatic cholangiocarcinoma paired patient derived xenograft and cell line. (Q38728270) (← links)
- Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy (Q38776694) (← links)
- Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). (Q38812588) (← links)
- Significant Improvement in Outcomes of Patients with Intrahepatic Cholangiocarcinoma after Surgery (Q38851999) (← links)
- HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target? (Q39040859) (← links)
- Biliary tract cancer stem cells - translational options and challenges. (Q39279276) (← links)
- Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study (Q39313846) (← links)
- Decision Making: Intra-arterial Therapies for Cholangiocarcinoma-TACE and TARE. (Q39349626) (← links)
- Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference (Q39673531) (← links)
- Expression of Bcl-2 19-kDa interacting protein 3 predicts prognosis after ampullary carcinoma resection (Q39702272) (← links)
- The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas (Q40436271) (← links)